• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lotilaner - a novel systemic tick and flea control product for dogs.

作者信息

Little Susan E

机构信息

Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, 74074, USA.

出版信息

Parasit Vectors. 2017 Nov 1;10(1):539. doi: 10.1186/s13071-017-2471-3.

DOI:10.1186/s13071-017-2471-3
PMID:29089062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5664799/
Abstract
摘要

相似文献

1
Lotilaner - a novel systemic tick and flea control product for dogs.洛替拉奈——一种用于犬类的新型全身性蜱蚤防治产品。
Parasit Vectors. 2017 Nov 1;10(1):539. doi: 10.1186/s13071-017-2471-3.
2
NEXGARD®. Afoxolaner, a new oral insecticide-acaricide to control fleas and ticks in dogs. Editorial.NEXGARD®。阿福拉纳，一种用于控制犬类跳蚤和蜱虫的新型口服杀虫杀螨剂。社论。
Vet Parasitol. 2014 Apr 2;201(3-4):177-8. doi: 10.1016/j.vetpar.2014.02.029. Epub 2014 Mar 12.
3
World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition: guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats.世界兽医寄生虫学会（W.A.A.V.P.）第二版：评估用于治疗、预防和控制犬猫跳蚤和蜱虫感染的杀寄生虫剂疗效的指南。
Vet Parasitol. 2013 May 1;194(1):84-97. doi: 10.1016/j.vetpar.2013.02.003.
4
Design and synthesis of sarolaner, a novel, once-a-month, oral isoxazoline for the control of fleas and ticks on dogs.沙罗拉纳的设计与合成，一种新型的每月口服一次的异恶唑啉类药物，用于防治犬只跳蚤和蜱虫。
Bioorg Med Chem Lett. 2016 Apr 1;26(7):1831-5. doi: 10.1016/j.bmcl.2016.02.027. Epub 2016 Feb 12.
5
Systemically and cutaneously distributed ectoparasiticides: a review of the efficacy against ticks and fleas on dogs.系统分布和皮肤分布的外寄生虫杀虫剂：对狗的蜱和跳蚤的疗效评价。
Parasit Vectors. 2016 Aug 8;9(1):436. doi: 10.1186/s13071-016-1719-7.
6
A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs.一项随机、双盲、对照、多中心的现场研究，比较了博来恩（氟虫腈）和福来恩（非泼罗尼）对跳蚤和蜱虫感染犬的疗效和安全性。
Parasit Vectors. 2014 Mar 4;7:83. doi: 10.1186/1756-3305-7-83.
7
Lotilaner - a novel formulation for cats provides systemic tick and flea control.洛替拉奈——一种用于猫的新型制剂，可提供全身性蜱虫和跳蚤防治。
Parasit Vectors. 2018 Jul 13;11(1):407. doi: 10.1186/s13071-018-2970-x.
8
The effect of water and shampooing on the efficacy of fluralaner spot-on solution against Ixodes ricinus and Ctenocephalides felis infestations in dogs.水和洗发对氟虫腈滴剂防治犬蓖麻硬蜱和猫栉首蚤感染效果的影响。
Parasit Vectors. 2016 May 31;9(1):233. doi: 10.1186/s13071-016-1367-y.
9
A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA.一项评估美国犬主拥有的犬中使用氯氟醚菊酯味咀嚼片（Credelio™）消除跳蚤的功效和安全性的随机对照田间研究。
Parasit Vectors. 2017 Nov 1;10(1):528. doi: 10.1186/s13071-017-2469-x.
10
Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio Plus) against natural flea and tick infestations on dogs presented as veterinary patients in Europe.一项在欧洲兽医就诊犬中进行的现场研究，旨在评估新型口服组合药物米尔贝肟和莫昔克丁（雷滴利诺）（Credelio Plus）对跳蚤和蜱自然感染的有效性和安全性。
Parasit Vectors. 2021 Jun 4;14(1):299. doi: 10.1186/s13071-021-04808-0.

引用本文的文献

1
Treatment and control of Haemaphysalis longicornis infestations on dogs using a formulation of sarolaner, moxidectin and pyrantel (Simparica Trio®).使用沙罗拉纳、莫昔克丁和吡喹酮制剂（速倍妥三效片®）治疗和控制犬的长角血蜱感染
Parasit Vectors. 2025 Mar 26;18(1):117. doi: 10.1186/s13071-025-06747-6.
2
Acaricidal and Repellent Effects of Essential Oils against Ticks: A Review.精油对蜱虫的杀螨和驱避作用：综述
Pathogens. 2021 Oct 26;10(11):1379. doi: 10.3390/pathogens10111379.
3
The molecular targets of ivermectin and lotilaner in the human louse Pediculus humanus humanus: New prospects for the treatment of pediculosis.伊维菌素和氯菊酯在人体虱（Pediculus humanus humanus）中的分子靶点：治疗头虱病的新前景。
PLoS Pathog. 2021 Feb 18;17(2):e1008863. doi: 10.1371/journal.ppat.1008863. eCollection 2021 Feb.
4
Clinical, Parasitological, and Serological Follow-Up of Dogs with Sarcoptic Mange Treated Orally with Lotilaner.口服洛替拉奈治疗犬疥螨病的临床、寄生虫学和血清学随访
Case Rep Vet Med. 2021 Jan 25;2021:6639017. doi: 10.1155/2021/6639017. eCollection 2021.
5
A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned cats in Europe.一项在欧洲进行的评估利替拉纳（Credelio™）控制宠物猫体内跳蚤的疗效和安全性的随机对照田间研究。
Parasit Vectors. 2018 Jul 13;11(1):411. doi: 10.1186/s13071-018-2967-5.
6
Safety of lotilaner flavoured chewable tablets (Credelio) after oral administration in cats.猫经口给予利来诺尔香草味咀嚼片（驱来特）的安全性。
Parasit Vectors. 2018 Jul 13;11(1):409. doi: 10.1186/s13071-018-2969-3.
7
Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio) against Ixodes ricinus ticks on cats.实验室评估利拉萘酯（立克宁）对猫体革螨的疗效和杀灭速度。
Parasit Vectors. 2018 Jul 13;11(1):413. doi: 10.1186/s13071-018-2968-4.
8
Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio™) against Ctenocephalides felis on cats.实验室评估氯氟醚菊酯（立宠）对猫栉首蚤的疗效和杀灭速度。
Parasit Vectors. 2018 Jul 13;11(1):408. doi: 10.1186/s13071-018-2972-8.
9
Pharmacokinetics of lotilaner following a single oral or intravenous administration in cats.猫单次口服或静脉给药后洛替拉纳的药代动力学。
Parasit Vectors. 2018 Jul 13;11(1):412. doi: 10.1186/s13071-018-2966-6.
10
A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment.单次局部应用氟雷拉纳即可有效控制猫和犬跳蚤 12 周，该结果在模拟家庭环境中得到验证。
Parasit Vectors. 2018 Jul 3;11(1):385. doi: 10.1186/s13071-018-2927-0.

本文引用的文献

1
Therapy, control and prevention of flea allergy dermatitis in dogs and cats.犬猫跳蚤过敏性皮炎的治疗、控制与预防。
Vet Dermatol. 2000 Jun;11(2):83-98. doi: 10.1046/j.1365-3164.2000.00204.x.
2
Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio) against Ixodes ricinus ticks on cats.实验室评估利拉萘酯（立克宁）对猫体革螨的疗效和杀灭速度。
Parasit Vectors. 2018 Jul 13;11(1):413. doi: 10.1186/s13071-018-2968-4.
3
Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs.评估落健（CredelioTM）杀死犬跳蚤的起效速度。
Parasit Vectors. 2017 Nov 1;10(1):521. doi: 10.1186/s13071-017-2474-0.
4
A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries.一项在欧洲国家进行的评估利来特罗片剂（Credelio™）控制犬跳蚤的有效性和安全性的随机、双盲、对照现场研究。
Parasit Vectors. 2017 Nov 1;10(1):526. doi: 10.1186/s13071-017-2479-8.
5
A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA.一项评估美国犬主拥有的犬中使用氯氟醚菊酯味咀嚼片（Credelio™）消除跳蚤的功效和安全性的随机对照田间研究。
Parasit Vectors. 2017 Nov 1;10(1):528. doi: 10.1186/s13071-017-2469-x.
6
Laboratory evaluations of the immediate and sustained efficacy of lotilaner (Credelio™) against four common species of ticks affecting dogs in North America.实验室评价利马前列素（立宠）对北美的四种常见犬蜱的即时和持续疗效。
Parasit Vectors. 2017 Nov 1;10(1):523. doi: 10.1186/s13071-017-2476-y.
7
The intravenous and oral pharmacokinetics of lotilaner in dogs.在犬体内，洛替拉纳的静脉内和口服药代动力学。
Parasit Vectors. 2017 Nov 1;10(1):522. doi: 10.1186/s13071-017-2475-z.
8
Laboratory evaluations of the immediate and sustained effectiveness of lotilaner (Credelio™) against three common species of ticks affecting dogs in Europe.实验室评估了利托那君（Credelio™）对影响欧洲犬类的三种常见蜱虫的即时和持续有效性。
Parasit Vectors. 2017 Nov 1;10(1):527. doi: 10.1186/s13071-017-2477-x.
9
Safety evaluation of lotilaner in dogs after oral administration as flavoured chewable tablets (Credelio™).口服赋形剂咀嚼片（CredelioTM）在犬中的安全性评价。
Parasit Vectors. 2017 Nov 1;10(1):538. doi: 10.1186/s13071-017-2468-y.
10
Assessment of the speed of flea kill of lotilaner (Credelio™) throughout the month following oral administration to dogs.评估口服洛匹那韦（Credelio™）后整个月内跳蚤杀灭速度。
Parasit Vectors. 2017 Nov 1;10(1):529. doi: 10.1186/s13071-017-2466-0.